Takaisin Tulosta

Epävakaa persoonallisuus, näytönastekatsausten kirjallisuusviitteet

Lisätietoa aiheesta
Käypä hoito -toimitus
20.5.2020

Kirjallisuusviiteluettelosta löytyy koottuna Käypä hoito -suosituksen Epävakaa persoonallisuus «Epävakaa persoonallisuus»1 näytönastekatsauksissa arvioitu kirjallisuus.

Kirjallisuutta

  1. Abraham PF, Calabrese JR. Evidenced-based pharmacologic treatment of borderline personality disorder: a shift from SSRIs to anticonvulsants and atypical antipsychotics? J Affect Disord 2008;111:21-30 «PMID: 18304647»PubMed
  2. Acklin MW, McDowell CJ 2nd, Verschell MS ym. Interobserver agreement, intraobserver reliability, and the Rorschach Comprehensive System. J Pers Assess 2000;74:15-47 «PMID: 10779931»PubMed
  3. Agrawal HR, Gunderson J, Holmes BM ym. Attachment studies with borderline patients: a review. Harv Rev Psychiatry 2004;12:94-104 «PMID: 15204804»PubMed
  4. Akiskal HS, Akiskal KK, Perugi G ym. Bipolar II and anxious reactive "comorbidity": toward better phenotypic characterization suitable for genotyping. J Affect Disord 2006;96:239-47 «PMID: 16973219»PubMed
  5. American Psychiatric Association. Practice guideline for the assessment and treatment of patients with suicidal behaviors. Am J Psychiatry 2003;160 (Suppl.):1–52
  6. Andover MS, Pepper CM, Ryabchenko KA ym. Self-mutilation and symptoms of depression, anxiety, and borderline personality disorder. Suicide Life Threat Behav 2005;35:581-91 «PMID: 16268774»PubMed
  7. Arntz A, Dietzel R, Dreessen L. Assumptions in borderline personality disorder: specificity, stability and relationship with etiological factors. Behav Res Ther 1999;37:545-57 «PMID: 10372468»PubMed
  8. Arntz A, Veen G. Evaluations of others by borderline patients. J Nerv Ment Dis 2001;189:513-21 «PMID: 11531203»PubMed
  9. Aronen E, Kuosa M, Tallila M ym. Kotikäynteihin perustuvan perheneuvonnan vaikutus nuoren psyykkiseen terveyteen - 15 vuoden seurantatutkimus. Duodecim 1995;111:505–9 «http://www.duodecimlehti.fi/web/guest/etusivu/artikkeli?tunnus=duo50130»1
  10. Baity MR, Blais MA, Hilsenroth MJ ym. Self-mutilation, severity of borderline psychopathology, and the Rorschach. Bull Menninger Clin 2009;73:203-25 «PMID: 19807224»PubMed
  11. Bales D, van Beek N, Smits M ym. Treatment outcome of 18-month, day hospital mentalization-based treatment (MBT) in patients with severe borderline personality disorder in the Netherlands. J Pers Disord 2012;26:568-82 «PMID: 22867507»PubMed
  12. Bamelis LL, Evers SM, Spinhoven P ym. Results of a multicenter randomized controlled trial of the clinical effectiveness of schema therapy for personality disorders. Am J Psychiatry 2014;171:305-22 «PMID: 24322378»PubMed
  13. Bateman A, Fonagy P. 8-year follow-up of patients treated for borderline personality disorder: mentalization-based treatment versus treatment as usual. Am J Psychiatry 2008;165:631-8 «PMID: 18347003»PubMed
  14. Bateman A, Fonagy P. Effectiveness of partial hospitalization in the treatment of borderline personality disorder: a randomized controlled trial. Am J Psychiatry 1999;156:1563-9 «PMID: 10518167»PubMed
  15. Bateman A, Fonagy P. Randomized controlled trial of outpatient mentalization-based treatment versus structured clinical management for borderline personality disorder. Am J Psychiatry 2009;166:1355-64 «PMID: 19833787»PubMed
  16. Bateman A, Fonagy P. Treatment of borderline personality disorder with psychoanalytically oriented partial hospitalization: an 18-month follow-up. Am J Psychiatry 2001;158:36-42 «PMID: 11136631»PubMed
  17. Becker DF, Grilo CM, Edell WS ym. Comorbidity of borderline personality disorder with other personality disorders in hospitalized adolescents and adults. Am J Psychiatry 2000;157:2011-6 «PMID: 11097968»PubMed
  18. Berrino A, Ohlendorf P, Duriaux S ym. Crisis intervention at the general hospital: an appropriate treatment choice for acutely suicidal borderline patients. Psychiatry Res 2011;186:287-92 «PMID: 20667602»PubMed
  19. Biskin RS, Frankenburg FR, Fitzmaurice GM ym. Pain in patients with borderline personality disorder. Personal Ment Health 2014;8:218-27 «PMID: 25044742»PubMed
  20. Black DW, Blum N, Pfohl B ym. Suicidal behavior in borderline personality disorder: prevalence, risk factors, prediction, and prevention. J Pers Disord 2004;18:226-39 «PMID: 15237043»PubMed
  21. Black DW, Zanarini MC, Romine A ym. Comparison of low and moderate dosages of extended-release quetiapine in borderline personality disorder: a randomized, double-blind, placebo-controlled trial. Am J Psychiatry 2014;171:1174-82 «PMID: 24968985»PubMed
  22. Blum N, St John D, Pfohl B ym. Systems Training for Emotional Predictability and Problem Solving (STEPPS) for outpatients with borderline personality disorder: a randomized controlled trial and 1-year follow-up. Am J Psychiatry 2008;165:468-78 «PMID: 18281407»PubMed
  23. Bornovalova MA, Hicks BM, Iacono WG ym. Stability, change, and heritability of borderline personality disorder traits from adolescence to adulthood: a longitudinal twin study. Dev Psychopathol 2009;21:1335-53 «PMID: 19825271»PubMed
  24. Bos EH, van Wel EB, Appelo MT ym. A randomized controlled trial of a Dutch version of systems training for emotional predictability and problem solving for borderline personality disorder. J Nerv Ment Dis 2010;198:299-304 «PMID: 20386260»PubMed
  25. Bos EH, van Wel EB, Appelo MT ym. Effectiveness of Systems Training for Emotional Predictability and Problem Solving (STEPPS) for borderline personality problems in a 'real-world' sample: moderation by diagnosis or severity? Psychother Psychosom 2011;80:173-81 «PMID: 21389754»PubMed
  26. Brazier J, Tumur I, Holmes M ym. Psychological therapies including dialectical behaviour therapy for borderline personality disorder: a systematic review and preliminary economic evaluation. Health Technol Assess 2006;10:iii, ix-xii, 1-117 «PMID: 16959171»PubMed
  27. Carter GL, Willcox CH, Lewin TJ ym. Hunter DBT project: randomized controlled trial of dialectical behaviour therapy in women with borderline personality disorder. Aust N Z J Psychiatry 2010;44:162-73 «PMID: 20113305»PubMed
  28. Chang HH, Yen ST. Association between obesity and depression: evidence from a longitudinal sample of the elderly in Taiwan. Aging Ment Health 2012;16:173-80 «PMID: 21861766»PubMed
  29. Chiesa M, Fonagy P, Holmes J ym. Residential versus community treatment of personality disorders: a comparative study of three treatment programs. Am J Psychiatry 2004;161:1463-70 «PMID: 15285974»PubMed
  30. Clarke SB, Rizvi SL, Resick PA. Borderline personality characteristics and treatment outcome in cognitive-behavioral treatments for PTSD in female rape victims. Behav Ther 2008;39:72-8 «PMID: 18328872»PubMed
  31. Coccaro EF, Kavoussi RJ. Fluoxetine and impulsive aggressive behavior in personality-disordered subjects. Arch Gen Psychiatry 1997;54:1081-8 «PMID: 9400343»PubMed
  32. Cowry RW, Gardner DL. Pharmacotherapy of borderline personality disorder: alprazolam, carbamazepine, trifluoperazine, and tranylcypromine. Arch Gen Psychiatry 1988;45:111–9
  33. Dahl AA. Some aspects of the DSM-III personality disorders illustrated by a consecutive sample of hospitalized patients. Acta Psychiatr Scand Suppl 1986;328:61-7 «PMID: 3463140»PubMed
  34. Davidson K, Norrie J, Tyrer P ym. The effectiveness of cognitive behavior therapy for borderline personality disorder: results from the borderline personality disorder study of cognitive therapy (BOSCOT) trial. J Pers Disord 2006;20:450-65 «PMID: 17032158»PubMed
  35. Davidson K, Tyrer P, Gumley A ym. A randomized controlled trial of cognitive behavior therapy for borderline personality disorder: rationale for trial, method, and description of sample. J Pers Disord 2006;20:431-49 «PMID: 17032157»PubMed
  36. Davidson KM, Tyrer P, Norrie J ym. Cognitive therapy v. usual treatment for borderline personality disorder: prospective 6-year follow-up. Br J Psychiatry 2010;197:456-62 «PMID: 21119151»PubMed
  37. de la Fuente JM, Lotstra F. A trial of carbamazepine in borderline personality disorder. Eur Neuropsychopharmacol 1994;4:479-86 «PMID: 7894258»PubMed
  38. De Panfilis C, Politi V, Fortunati R ym. Two-year follow-up of borderline personality disorder patients in Italy: a preliminary report on prognosis and prediction of outcome. Int J Soc Psychiatry 2011;57:528-37 «PMID: 20603267»PubMed
  39. Doering S, Hörz S, Rentrop M ym. Transference-focused psychotherapy v. treatment by community psychotherapists for borderline personality disorder: randomised controlled trial. Br J Psychiatry 2010;196:389-95 «PMID: 20435966»PubMed
  40. Dreessen L, Arntz A. Short-interval test-retest interrater reliability of the Structured Clinical Interview for DSM-III-R personality disorders (SCID-II) in outpatients. J Pers Disord 1998;12:138-48 «PMID: 9661100»PubMed
  41. Edell WS. Role of structure in disordered thinking in borderline and schizophrenic disorders. J Pers Assess 1987;51:23-41 «PMID: 3572709»PubMed
  42. Fan AH, Hassell J. Bipolar disorder and comorbid personality psychopathology: a review of the literature. J Clin Psychiatry 2008;69:1794-803 «PMID: 19026249»PubMed
  43. Farrell JM, Shaw IA, Webber MA. A schema-focused approach to group psychotherapy for outpatients with borderline personality disorder: a randomized controlled trial. J Behav Ther Exp Psychiatry 2009;40:317-28 «PMID: 19176222»PubMed
  44. Favaro A, Santonastaso P. Impulsive and compulsive self-injurious behavior in bulimia nervosa: prevalence and psychological correlates. J Nerv Ment Dis 1998;186:157-65 «PMID: 9521351»PubMed
  45. Favazza AR, Conterio K. Female habitual self-mutilators. Acta Psychiatr Scand 1989;79:283-9 «PMID: 2711856»PubMed
  46. Favazza AR. Why patients mutilate themselves. Hosp Community Psychiatry 1989;40:137-45 «PMID: 2644160»PubMed
  47. Ferro T, Klein DN, Schwartz JE ym. 30-month stability of personality disorder diagnoses in depressed outpatients. Am J Psychiatry 1998;155:653-9 «PMID: 9585717»PubMed
  48. Fertuck EA, Lenzenweger MF, Clarkin JF ym. Executive neurocognition, memory systems, and borderline personality disorder. Clin Psychol Rev 2006;26:346-75 «PMID: 15992977»PubMed
  49. Feske U, Tarter RE, Kirisci L ym. Borderline personality and substance use in women. Am J Addict 2006;15:131-7 «PMID: 16595350»PubMed
  50. Feurino L 3rd, Silk KR. State of the art in the pharmacologic treatment of borderline personality disorder. Curr Psychiatry Rep 2011;13:69-75 «PMID: 21140245»PubMed
  51. Fine MA, Sansone RA. Dilemmas in the management of suicidal behavior in individuals with borderline personality disorder. Am J Psychother 1990;44:160-71 «PMID: 2195899»PubMed
  52. First MB, Spitzer RL, Gibbon M ym. The structured clinical interview for DSM-III Personality Disorders (SCID-II): part II: multi-site test–retest reliability study. J Pers Disord 1995:9:92–104
  53. Fonagy P, Bateman A. Progress in the treatment of borderline personality disorder. Br J Psychiatry 2006;188:1-3 «PMID: 16388061»PubMed
  54. Fonagy P, Leigh T, Steele M ym. The relation of attachment status, psychiatric classification, and response to psychotherapy. J Consult Clin Psychol 1996;64:22-31 «PMID: 8907081»PubMed
  55. Frankenburg FR, Zanarini MC. Divalproex sodium treatment of women with borderline personality disorder and bipolar II disorder: a double-blind placebo-controlled pilot study. J Clin Psychiatry 2002;63:442-6 «PMID: 12019669»PubMed
  56. Gardner F, Shaw DS, Dishion TJ ym. Randomized prevention trial for early conduct problems: effects on proactive parenting and links to toddler disruptive behavior. J Fam Psychol 2007;21:398-406 «PMID: 17874925»PubMed
  57. Giesen-Bloo J, van Dyck R, Spinhoven P ym. Outpatient psychotherapy for borderline personality disorder: randomized trial of schema-focused therapy vs transference-focused psychotherapy. Arch Gen Psychiatry 2006;63:649-58 «PMID: 16754838»PubMed
  58. Gross D, Fogg L, Webster-Stratton C ym. Parent training of toddlers in day care in low-income urban communities. J Consult Clin Psychol 2003;71:261-78 «PMID: 12699021»PubMed
  59. Guarnaccia V, Dill CA, Sabatino S ym. Scoring accuracy using the comprehensive system for the Rorschach. J Pers Assess 2001;77:464-74 «PMID: 11781033»PubMed
  60. Gunderson JG, Stout RL, McGlashan TH ym. Ten-year course of borderline personality disorder: psychopathology and function from the Collaborative Longitudinal Personality Disorders study. Arch Gen Psychiatry 2011;68:827-37 «PMID: 21464343»PubMed
  61. Haaland VØ, Esperaas L, Landrø NI. Selective deficit in executive functioning among patients with borderline personality disorder. Psychol Med 2009;39:1733-43 «PMID: 19243646»PubMed
  62. Harned MS, Chapman AL, Dexter-Mazza ET ym. Treating co-occurring Axis I disorders in recurrently suicidal women with borderline personality disorder: a 2-year randomized trial of dialectical behavior therapy versus community treatment by experts. J Consult Clin Psychol 2008;76:1068-75 «PMID: 19045974»PubMed
  63. Harris D. The prevalence of thought disorder in personality-disordered outpatients. J Pers Assess 1993;61:112-20 «PMID: 8377096»PubMed
  64. Hawton K, Townsend E, Arensman E ym. Psychosocial versus pharmacological treatments for deliberate self harm. Cochrane Database Syst Rev 1999;4:CD001764 «PMID: 10796818»PubMed
  65. Henry C, Mitropoulou V, New AS ym. Affective instability and impulsivity in borderline personality and bipolar II disorders: similarities and differences. J Psychiatr Res 2001;35:307-12 «PMID: 11684137»PubMed
  66. Herpertz S, Sass H, Favazza A. Impulsivity in self-mutilative behavior: psychometric and biological findings. J Psychiatr Res 1997;31:451-65 «PMID: 9352472»PubMed
  67. Herpertz S. Self-injurious behaviour. Psychopathological and nosological characteristics in subtypes of self-injurers. Acta Psychiatr Scand 1995;91:57-68 «PMID: 7754789»PubMed
  68. Hollander E, Allen A, Lopez RP ym. A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder. J Clin Psychiatry 2001;62:199-203 «PMID: 11305707»PubMed
  69. Hollander E, Swann AC, Coccaro EF ym. Impact of trait impulsivity and state aggression on divalproex versus placebo response in borderline personality disorder. Am J Psychiatry 2005;162:621-4 «PMID: 15741486»PubMed
  70. Hollander E, Tracy KA, Swann AC ym. Divalproex in the treatment of impulsive aggression: efficacy in cluster B personality disorders. Neuropsychopharmacology 2003;28:1186-97 «PMID: 12700713»PubMed
  71. Huband N, McMurran M, Evans C ym. Social problem-solving plus psychoeducation for adults with personality disorder: pragmatic randomised controlled trial. Br J Psychiatry 2007;190:307-13 «PMID: 17401036»PubMed
  72. Hueston WJ, Werth J, Mainous AG 3rd. Personality disorder traits: prevalence and effects on health status in primary care patients. Int J Psychiatry Med 1999;29:63-74 «PMID: 10376233»PubMed
  73. Ingenhoven TJM, Duivenvoorden HJ. Differential effectiveness of antipsychotics in borderline personality disorder: meta-analyses of placebo-controlled, randomized clinical trials on symptomatic outcome domains. J Clin Psychopharmacol 2011;31:489–96
  74. Isometsä ET, Henriksson MM, Heikkinen ME ym. Suicide among subjects with personality disorders. Am J Psychiatry 1996;153:667-73 «PMID: 8615412»PubMed
  75. Johnson JG, Cohen P, Kasen S ym. Age-related change in personality disorder trait levels between early adolescence and adulthood: a community-based longitudinal investigation. Acta Psychiatr Scand 2000;102:265-75 «PMID: 11089726»PubMed
  76. Johnson MK, Hashtroudi S, Lindsay DS. Source monitoring. Psychol Bull 1993;114:3-28 «PMID: 8346328»PubMed
  77. Joyce PR, Light KJ, Rowe SL ym. Self-mutilation and suicide attempts: relationships to bipolar disorder, borderline personality disorder, temperament and character. Aust N Z J Psychiatry 2010;44:250-7 «PMID: 20180727»PubMed
  78. Kahl KG, Greggersen W, Schweiger U ym. Prevalence of the metabolic syndrome in patients with borderline personality disorder: results from a cross-sectional study. Eur Arch Psychiatry Clin Neurosci 2013;263:205-13 «PMID: 22777277»PubMed
  79. Kernberg O, Selzer M, Koenigsberg H, Carr A, Appelbaum A. Psychodynamic Psychotherapy of Borderline Patients. New York; Basic Books Inc. Publishers 1989
  80. Klonsky ED, Oltmanns TF, Turkheimer E. Deliberate self-harm in a nonclinical population: prevalence and psychological correlates. Am J Psychiatry 2003;160:1501-8 «PMID: 12900314»PubMed
  81. Koeningsberg HW, Anwunah I, New AS ym. Relationship between depression and borderline personality disorder. Depress Anxiety 1999;10:158–67
  82. Koons CR, Robins CJ, Tweed JL ym. Efficacy of dialectical behaviour therapy in women veterans with borderline personality disorder. Behav Ther 2001;32:371–90
  83. Kröger C, Schweiger U, Sipos V ym. Dialectical behaviour therapy and an added cognitive behavioural treatment module for eating disorders in women with borderline personality disorder and anorexia nervosa or bulimia nervosa who failed to respond to previous treatments. An open trial with a 15-month follow-up. J Behav Ther Exp Psychiatry 2010;41:381-8 «PMID: 20444442»PubMed
  84. Legris J, Links PS, van Reekum R ym. Executive function and suicidal risk in women with Borderline Personality Disorder. Psychiatry Res 2012;196:101-8 «PMID: 22377570»PubMed
  85. Lehtinen V, Veijola J, Lindholm T, Väisänen E, Moring J, Puukka P. Mielenterveyden pysyvyys ja muutokset suomalaisilla. UKKI-tutkimuksen 16-vuotisseurannan päätulokset. Turku: Kansaneläkelaitoksen julkaisuja 1993
  86. Leiberich P, Nickel MK, Tritt K ym. Lamotrigine treatment of aggression in female borderline patients, Part II: an 18-month follow-up. J Psychopharmacol 2008;22:805-8 «PMID: 18308777»PubMed
  87. Leichsenring F, Rabung S, Leibing E. The efficacy of short-term psychodynamic psychotherapy in specific psychiatric disorders: a meta-analysis. Arch Gen Psychiatry 2004;61:1208-16 «PMID: 15583112»PubMed
  88. Lenzenweger MF, Johnson MD, Willett JB. Individual growth curve analysis illuminates stability and change in personality disorder features: the longitudinal study of personality disorders. Arch Gen Psychiatry 2004;61:1015-24 «PMID: 15466675»PubMed
  89. Lieb K, Völlm B, Rücker G ym. Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trials. Br J Psychiatry 2010;196:4-12 «PMID: 20044651»PubMed
  90. Lieb K, Zanarini MC, Schmahl C ym. Borderline personality disorder. Lancet 2004;364:453-61 «PMID: 15288745»PubMed
  91. Lilienfeld SO, Wood JM, Garb HN. The scientific status of projective techniques. Psychol Sci Public Interest 2000;1:27–66
  92. Linehan MM, Armstrong HE, Suarez A ym. Cognitive-behavioral treatment of chronically parasuicidal borderline patients. Arch Gen Psychiatry 1991;48:1060-4 «PMID: 1845222»PubMed
  93. Linehan MM, Comtois KA, Murray AM ym. Two-year randomized controlled trial and follow-up of dialectical behavior therapy vs therapy by experts for suicidal behaviors and borderline personality disorder. Arch Gen Psychiatry 2006;63:757-66 «PMID: 16818865»PubMed
  94. Linehan MM, Dimeff LA, Reynolds SK ym. Dialectical behavior therapy versus comprehensive validation therapy plus 12-step for the treatment of opioid dependent women meeting criteria for borderline personality disorder. Drug Alcohol Depend 2002;67:13-26 «PMID: 12062776»PubMed
  95. Linehan MM, Heard HL, Armstrong HE. Naturalistic follow-up of a behavioral treatment for chronically parasuicidal borderline patients. Arch Gen Psychiatry 1993;50:971-4 «PMID: 8250683»PubMed
  96. Linehan MM, McDavid JD, Brown MZ ym. Olanzapine plus dialectical behavior therapy for women with high irritability who meet criteria for borderline personality disorder: a double-blind, placebo-controlled pilot study. J Clin Psychiatry 2008;69:999-1005 «PMID: 18466045»PubMed
  97. Linehan MM, Schmidt H 3rd, Dimeff LA ym. Dialectical behavior therapy for patients with borderline personality disorder and drug-dependence. Am J Addict 1999;8:279-92 «PMID: 10598211»PubMed
  98. Linehan MM, Tutek DA, Heard HL ym. Interpersonal outcome of cognitive behavioral treatment for chronically suicidal borderline patients. Am J Psychiatry 1994;151:1771-6 «PMID: 7977884»PubMed
  99. Links PS, Heslegrave R, van Reekum R. Prospective follow-up study of borderline personality disorder: prognosis, prediction of outcome, and Axis II comorbidity. Can J Psychiatry 1998;43:265-70 «PMID: 9561315»PubMed
  100. Links PS, Heslegrave RJ. Prospective studies of outcome. Understanding mechanisms of change in patients with borderline personality disorder. Psychiatr Clin North Am 2000;23:137-50 «PMID: 10729936»PubMed
  101. Links PS, Steiner M, Boiago I, Irwin D. Lithium therapy for borderline patients: preliminary findings. J Pers Disord 1990;4:173–81
  102. Liotti G, Pasquini P. Predictive factors for borderline personality disorder: patients' early traumatic experiences and losses suffered by the attachment figure. The Italian Group for the Study of Dissociation. Acta Psychiatr Scand 2000;102:282-9 «PMID: 11089728»PubMed
  103. Lobbestael J, Arntz A, Sieswerda S. Schema modes and childhood abuse in borderline and antisocial personality disorders. J Behav Ther Exp Psychiatry 2005;36:240-53 «PMID: 15953584»PubMed
  104. Loew TH, Nickel MK, Muehlbacher M ym. Topiramate treatment for women with borderline personality disorder: a double-blind, placebo-controlled study. J Clin Psychopharmacol 2006;26:61-6 «PMID: 16415708»PubMed
  105. Maffei C, Fossati A, Agostoni I ym. Interrater reliability and internal consistency of the structured clinical interview for DSM-IV axis II personality disorders (SCID-II), version 2.0. J Pers Disord 1997;11:279-84 «PMID: 9348491»PubMed
  106. Maier W, Minges J, Lichtermann D ym. Personality disorders and personality variations in relatives of patients with bipolar affective disorders. J Affect Disord 1995;35:173-81 «PMID: 8749982»PubMed
  107. Marinangeli MG, Butti G, Scinto A ym. Patterns of comorbidity among DSM-III-R personality disorders. Psychopathology 2000;33:69-74 «PMID: 10705249»PubMed
  108. McGlashan TH, Grilo CM, Skodol AE ym. The Collaborative Longitudinal Personality Disorders Study: baseline Axis I/II and II/II diagnostic co-occurrence. Acta Psychiatr Scand 2000;102:256-64 «PMID: 11089725»PubMed
  109. McGrath RE, Pogge DL, Stokes JM ym. Field reliability of comprehensive system scoring in an adolescent inpatient sample. Assessment 2005;12:199-209 «PMID: 15914721»PubMed
  110. McMain SF, Links PS, Gnam WH ym. A randomized trial of dialectical behavior therapy versus general psychiatric management for borderline personality disorder. Am J Psychiatry 2009;166:1365-74 «PMID: 19755574»PubMed
  111. Melartin T. Comorbidity, outcome and treatment of DSM-IV major depressive disorder in psychiatric care. Helsinki: National Public Health Institute: University of Helsinki 2004
  112. Mercer D, Douglass AB, Links PS. Meta-analyses of mood stabilizers, antidepressants and antipsychotics in the treatment of borderline personality disorder: effectiveness for depression and anger symptoms. J Pers Disord 2009;23:156-74 «PMID: 19379093»PubMed
  113. Mihura JL, Nathan-Montano E, Alperin RJ. Rorschach measures of aggressive drive derivatives: a college student sample. J Pers Assess 2003;80:41-9 «PMID: 12584066»PubMed
  114. Minzenberg MJ, Fisher-Irving M, Poole JH ym. Reduced Self-Referential Source Memory Performance is Associated with Interpersonal Dysfunction in Borderline Personality Disorder. J Pers Disord 2006;20:42-54 «PMID: 16563078»PubMed
  115. Minzenberg MJ, Poole JH, Vinogradov S. Adult social attachment disturbance is related to childhood maltreatment and current symptoms in borderline personality disorder. J Nerv Ment Dis 2006;194:341-8 «PMID: 16699383»PubMed
  116. Nicholson B, Anderson M, Fox R, Brenner V. One family at a time: a prevention program for at-risk parents. J Counsel Develop 2002;80:362–71
  117. Nickel MK, Loew TH. Treatment of aggression with topiramate in male borderline patients, part II: 18-month follow-up. Eur Psychiatry 2008;23:115-7 «PMID: 18024088»PubMed
  118. Nickel MK, Muehlbacher M, Nickel C ym. Aripiprazole in the treatment of patients with borderline personality disorder: a double-blind, placebo-controlled study. Am J Psychiatry 2006;163:833-8 «PMID: 16648324»PubMed
  119. Nickel MK, Nickel C, Kaplan P ym. Treatment of aggression with topiramate in male borderline patients: a double-blind, placebo-controlled study. Biol Psychiatry 2005;57:495-9 «PMID: 15737664»PubMed
  120. Nigg JT, Goldsmith HH. Genetics of personality disorders: perspectives from personality and psychopathology research. Psychol Bull 1994;115:346-80 «PMID: 8016285»PubMed
  121. Nijman HL, Dautzenberg M, Merckelbach HL ym. Self-mutilating behaviour of psychiatric inpatients. Eur Psychiatry 1999;14:4-10 «PMID: 10572319»PubMed
  122. Nordahl HM, Nysaeter TE. Schema therapy for patients with borderline personality disorder: a single case series. J Behav Ther Exp Psychiatry 2005;36:254-64 «PMID: 15978543»PubMed
  123. Nosè M, Cipriani A, Biancosino B ym. Efficacy of pharmacotherapy against core traits of borderline personality disorder: meta-analysis of randomized controlled trials. Int Clin Psychopharmacol 2006;21:345-53 «PMID: 17012981»PubMed
  124. Oldham JM, Skodol AE, Kellman HD ym. Diagnosis of DSM-III-R personality disorders by two structured interviews: patterns of comorbidity. Am J Psychiatry 1992;149:213-20 «PMID: 1734742»PubMed
  125. Paris J. Is hospitalization useful for suicidal patients with borderline personality disorder? J Pers Disord 2004;18:240-7 «PMID: 15237044»PubMed
  126. Pascual JC, Martín-Blanco A, Soler J ym. A naturalistic study of changes in pharmacological prescription for borderline personality disorder in clinical practice: from APA to NICE guidelines. Int Clin Psychopharmacol 2010;25:349-55 «PMID: 20838221»PubMed
  127. Pascual JC, Soler J, Puigdemont D ym. Ziprasidone in the treatment of borderline personality disorder: a double-blind, placebo-controlled, randomized study. J Clin Psychiatry 2008;69:603-8 «PMID: 18251623»PubMed
  128. Perugi G, Angst J, Azorin JM ym. Is comorbid borderline personality disorder in patients with major depressive episode and bipolarity a developmental subtype? Findings from the international BRIDGE study. J Affect Disord 2013;144:72-8 «PMID: 22858216»PubMed
  129. Pierce DW. The predictive validation of a suicide intent scale: a five year follow-up. Br J Psychiatry 1981;139:391-6 «PMID: 7332842»PubMed
  130. Pirkola SP, Isometsä E, Suvisaari J ym. DSM-IV mood-, anxiety- and alcohol use disorders and their comorbidity in the Finnish general population--results from the Health 2000 Study. Soc Psychiatry Psychiatr Epidemiol 2005;40:1-10 «PMID: 15624068»PubMed
  131. Posner MI, Rothbart MK, Vizueta N ym. Attentional mechanisms of borderline personality disorder. Proc Natl Acad Sci U S A 2002;99:16366-70 «PMID: 12456876»PubMed
  132. Practice guideline for the assessment and treatment of patients with suicidal behaviors. Am J Psychiatry 2003;160:1-60 «PMID: 14649920»PubMed
  133. Pulakos J. Two models of suicide treatment: evaluation and recommendations. Am J Psychother 1993;47:603-12 «PMID: 8285304»PubMed
  134. Reich DB, Zanarini MC, Bieri KA. A preliminary study of lamotrigine in the treatment of affective instability in borderline personality disorder. Int Clin Psychopharmacol 2009;24:270-5 «PMID: 19636254»PubMed
  135. Rifkin A, Levitan SJ, Galewski J ym. Emotionally unstable character disorder--a follow-up study. I. Description of patients and outcome. Biol Psychiatry 1972;4:65-79 «PMID: 5020699»PubMed
  136. Rinne T, van den Brink W, Wouters L ym. SSRI treatment of borderline personality disorder: a randomized, placebo-controlled clinical trial for female patients with borderline personality disorder. Am J Psychiatry 2002;159:2048-54 «PMID: 12450955»PubMed
  137. Ripoll LH. Clinical psychopharmacology of borderline personality disorder: an update on the available evidence in light of the Diagnostic and Statistical Manual of Mental Disorders - 5. Curr Opin Psychiatry 2012;25:52-8 «PMID: 22037092»PubMed
  138. Roberts BW, Walton KE, Viechtbauer W. Patterns of mean-level change in personality traits across the life course: a meta-analysis of longitudinal studies. Psychol Bull 2006;132:1-25 «PMID: 16435954»PubMed
  139. Rosenthal RJ, Rinzler C, Wallsh R ym. Wrist-cutting syndrome: the meaning of a gesture. Am J Psychiatry 1972;128:1363-8 «PMID: 5020184»PubMed
  140. Roy A. Self-mutilation. Br J Med Psychol 1978;51:201-3 «PMID: 646965»PubMed
  141. Ruocco AC. The neuropsychology of borderline personality disorder: a meta-analysis and review. Psychiatry Res 2005;137:191-202 «PMID: 16297985»PubMed
  142. Sachsse U, Vogel C, Leichsenring F. Results of psychodynamically oriented trauma-focused inpatient treatment for women with complex posttraumatic stress disorder (PTSD) and borderline personality disorder (BPD). Bull Menninger Clin 2006;70:125-44 «PMID: 16753036»PubMed
  143. Salzman C, Wolfson AN, Schatzberg A ym. Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder. J Clin Psychopharmacol 1995;15:23-9 «PMID: 7714224»PubMed
  144. Sansone RA, Gaither GA, Songer DA. Self-harm behaviors across the life cycle: a pilot study of inpatients with borderline personality disorder. Compr Psychiatry 2002;43:215-8 «PMID: 11994840»PubMed
  145. Sansone RA, Whitecar P, Meier BP ym. The prevalence of borderline personality among primary care patients with chronic pain. Gen Hosp Psychiatry 2001;23:193-7 «PMID: 11543845»PubMed
  146. Sansone RA, Wiederman MW, Sansone LA ym. Obesity and borderline personality symptomatology: comparison of a psychiatric versus primary care sample. Int J Obes Relat Metab Disord 2001;25:299-300 «PMID: 11410836»PubMed
  147. Sansone RA, Wiederman MW, Sansone LA. Borderline personality symptomatology, experience of multiple types of trauma, and health care utilization among women in a primary care setting. J Clin Psychiatry 1998;59:108-11 «PMID: 9541152»PubMed
  148. Sansone RA. Chronic suicidality and borderline personality. J Pers Disord 2004;18:215-25 «PMID: 15237042»PubMed
  149. Schaffer CB, Carroll J, Abramowitz SI. Self-mutilation and the borderline personality. J Nerv Ment Dis 1982;170:468-73 «PMID: 7097263»PubMed
  150. Schulz SC, Zanarini MC, Bateman A ym. Olanzapine for the treatment of borderline personality disorder: variable dose 12-week randomised double-blind placebo-controlled study. Br J Psychiatry 2008;193:485-92 «PMID: 19043153»PubMed
  151. Segal DL, Hersen M, Van Hasselt VB. Reliability of the Structured Clinical Interview for DSM-III-R: an evaluative review. Compr Psychiatry 1994;35:316-27 «PMID: 7956189»PubMed
  152. Shea MT, Stout R, Gunderson J ym. Short-term diagnostic stability of schizotypal, borderline, avoidant, and obsessive-compulsive personality disorders. Am J Psychiatry 2002;159:2036-41 «PMID: 12450953»PubMed
  153. Silverman JM, Pinkham L, Horvath TB ym. Affective and impulsive personality disorder traits in the relatives of patients with borderline personality disorder. Am J Psychiatry 1991;148:1378-85 «PMID: 1897620»PubMed
  154. Simpson EB, Yen S, Costello E ym. Combined dialectical behavior therapy and fluoxetine in the treatment of borderline personality disorder. J Clin Psychiatry 2004;65:379-85 «PMID: 15096078»PubMed
  155. Skodol AE, Grilo CM, Pagano ME ym. Effects of personality disorders on functioning and well-being in major depressive disorder. J Psychiatr Pract 2005;11:363-8 «PMID: 16304504»PubMed
  156. Skodol AE, Gunderson JG, McGlashan TH ym. Functional impairment in patients with schizotypal, borderline, avoidant, or obsessive-compulsive personality disorder. Am J Psychiatry 2002;159:276-83 «PMID: 11823271»PubMed
  157. Skodol AE, Oldham JM, Gallaher PE. Axis II comorbidity of substance use disorders among patients referred for treatment of personality disorders. Am J Psychiatry 1999;156:733-8 «PMID: 10327906»PubMed
  158. Skodol AE, Pagano ME, Bender DS ym. Stability of functional impairment in patients with schizotypal, borderline, avoidant, or obsessive-compulsive personality disorder over two years. Psychol Med 2005;35:443-51 «PMID: 15841879»PubMed
  159. Skodol AE, Rosnick L, Kellman D ym. Validating structured DSM-III-R personality disorder assessments with longitudinal data. Am J Psychiatry 1988;145:1297-9 «PMID: 3421353»PubMed
  160. Soler J, Pascual JC, Tiana T ym. Dialectical behaviour therapy skills training compared to standard group therapy in borderline personality disorder: a 3-month randomised controlled clinical trial. Behav Res Ther 2009;47:353-8 «PMID: 19246029»PubMed
  161. Stanley B, Brodsky B, Nelson JD ym. Brief dialectical behavior therapy (DBT-B) for suicidal behavior and non-suicidal self injury. Arch Suicide Res 2007;11:337-41 «PMID: 17882621»PubMed
  162. Stern MI, Herron WG, Primavera LH ym. Interpersonal perceptions of depressed and borderline inpatients. J Clin Psychol 1997;53:41-9 «PMID: 9120031»PubMed
  163. Stoffers JM, Lieb K. Pharmacotherapy for borderline personality disorder--current evidence and recent trends. Curr Psychiatry Rep 2015;17:534 «PMID: 25413640»PubMed
  164. Svartberg M, Stiles TC, Seltzer MH. Randomized, controlled trial of the effectiveness of short-term dynamic psychotherapy and cognitive therapy for cluster C personality disorders. Am J Psychiatry 2004;161:810-7 «PMID: 15121645»PubMed
  165. Tidemalm D, Elofsson S, Stefansson CG ym. Predictors of suicide in a community-based cohort of individuals with severe mental disorder. Soc Psychiatry Psychiatr Epidemiol 2005;40:595-600 «PMID: 16091857»PubMed
  166. Torgensen S, Kringlen E, Cramer V. The prevalence of personality disorders in a community sample. Arch Gen Psychiatry 2001;58:590–6
  167. Tritt K, Nickel C, Lahmann C ym. Lamotrigine treatment of aggression in female borderline-patients: a randomized, double-blind, placebo-controlled study. J Psychopharmacol 2005;19:287-91 «PMID: 15888514»PubMed
  168. Turner RM. Naturalistic evaluation of dialectical behavior therapy-oriented treatment for borderline personality disorder. Cogn Behav Pract 2000;7:413–9
  169. Walter M, Gunderson JG, Zanarini MC ym. New onsets of substance use disorders in borderline personality disorder over 7 years of follow-ups: findings from the Collaborative Longitudinal Personality Disorders Study. Addiction 2009;104:97-103 «PMID: 19133893»PubMed
  170. van den Bosch LM, Koeter MW, Stijnen T ym. Sustained efficacy of dialectical behaviour therapy for borderline personality disorder. Behav Res Ther 2005;43:1231-41 «PMID: 16005708»PubMed
  171. van den Bosch LM, Verheul R, Schippers GM ym. Dialectical behavior therapy of borderline patients with and without substance use problems. Implementation and long-term effects. Addict Behav 2002;27:911-23 «PMID: 12369475»PubMed
  172. Waterhouse J, Platt S. General hospital admission in the management of parasuicide. A randomised controlled trial. Br J Psychiatry 1990;156:236-42 «PMID: 2180527»PubMed
  173. Weertman A, Arntz A, Dreessen L ym. Short-interval test-retest interrater reliability of the Dutch version of the Structured Clinical Interview for DSM-IV personality disorders (SCID-II). J Pers Disord 2003;17:562-7 «PMID: 14744081»PubMed
  174. Weinberg I, Gunderson JG, Hennen J ym. Manual assisted cognitive treatment for deliberate self-harm in borderline personality disorder patients. J Pers Disord 2006;20:482-92 «PMID: 17032160»PubMed
  175. Verheul R, Van Den Bosch LM, Koeter MW ym. Dialectical behaviour therapy for women with borderline personality disorder: 12-month, randomised clinical trial in The Netherlands. Br J Psychiatry 2003;182:135-40 «PMID: 12562741»PubMed
  176. Vijay NR, Links PS. New frontiers in the role of hospitalization for patients with personality disorders. Curr Psychiatry Rep 2007;9:63-7 «PMID: 17257516»PubMed
  177. Wilson ST, Stanley B, Oquendo MA ym. Comparing impulsiveness, hostility, and depression in borderline personality disorder and bipolar II disorder. J Clin Psychiatry 2007;68:1533-9 «PMID: 17960968»PubMed
  178. Winograd G, Cohen P, Chen H. Adolescent borderline symptoms in the community: prognosis for functioning over 20 years. J Child Psychol Psychiatry 2008;49:933-41 «PMID: 18665882»PubMed
  179. Vita A, De Peri L, Sacchetti E. Antipsychotics, antidepressants, anticonvulsants, and placebo on the symptom dimensions of borderline personality disorder: a meta-analysis of randomized controlled and open-label trials. J Clin Psychopharmacol 2011;31:613-24 «PMID: 21869691»PubMed
  180. Wood JM, Lilienfeld SO, Garb HN ym. The Rorschach test in clinical diagnosis: a critical review, with a backward look at Garfield (1947). J Clin Psychol 2000;56:395-430; discussion 431-4 «PMID: 10726675»PubMed
  181. Yen S, Shea MT, Sanislow CA ym. Borderline personality disorder criteria associated with prospectively observed suicidal behavior. Am J Psychiatry 2004;161:1296-8 «PMID: 15229066»PubMed
  182. Zanarini MC, Barison LK, Frankenburg FR ym. Family history study of the familial coaggregation of borderline personality disorder with axis I and nonborderline dramatic cluster axis II disorders. J Pers Disord 2009;23:357-69 «PMID: 19663656»PubMed
  183. Zanarini MC, Frankenburg FR, Hennen J ym. Mental health service utilization by borderline personality disorder patients and Axis II comparison subjects followed prospectively for 6 years. J Clin Psychiatry 2004;65:28-36 «PMID: 14744165»PubMed
  184. Zanarini MC, Frankenburg FR, Hennen J ym. Psychosocial functioning of borderline patients and axis II comparison subjects followed prospectively for six years. J Pers Disord 2005;19:19-29
  185. Zanarini MC, Frankenburg FR, Jager-Hyman S ym. The course of dissociation for patients with borderline personality disorder and axis II comparison subjects: a 10-year follow-up study. Acta Psychiatr Scand 2008;118:291-6 «PMID: 18759803»PubMed
  186. Zanarini MC, Frankenburg FR, Parachini EA. A preliminary, randomized trial of fluoxetine, olanzapine, and the olanzapine-fluoxetine combination in women with borderline personality disorder. J Clin Psychiatry 2004;65:903-7 «PMID: 15291677»PubMed
  187. Zanarini MC, Frankenburg FR, Reich DB ym. Attainment and stability of sustained symptomatic remission and recovery among patients with borderline personality disorder and axis II comparison subjects: a 16-year prospective follow-up study. Am J Psychiatry 2012;169:476-83 «PMID: 22737693»PubMed
  188. Zanarini MC, Frankenburg FR, Reich DB ym. The 10-year course of physically self-destructive acts reported by borderline patients and axis II comparison subjects. Acta Psychiatr Scand 2008;117:177-84 «PMID: 18241308»PubMed
  189. Zanarini MC, Frankenburg FR, Weingeroff JL ym. The course of substance use disorders in patients with borderline personality disorder and Axis II comparison subjects: a 10-year follow-up study. Addiction 2011;106:342-8 «PMID: 21083831»PubMed
  190. Zanarini MC, Frankenburg FR. A preliminary, randomized trial of psychoeducation for women with borderline personality disorder. J Pers Disord 2008;22:284-90 «PMID: 18540800»PubMed
  191. Zanarini MC, Laudate CS, Frankenburg FR ym. Predictors of self-mutilation in patients with borderline personality disorder: A 10-year follow-up study. J Psychiatr Res 2011;45:823-8 «PMID: 21129758»PubMed
  192. Zimmerman M, Coryell W. DSM-III personality disorder diagnoses in a nonpatient sample. Demographic correlates and comorbidity. Arch Gen Psychiatry 1989;46:682-9 «PMID: 2751402»PubMed
  193. Zimmerman M, Mattia JI. Axis I diagnostic comorbidity and borderline personality disorder. Compr Psychiatry 1999;40:245-52 «PMID: 10428182»PubMed
  194. Zittel Conklin C, Westen D. Borderline personality disorder in clinical practice. Am J Psychiatry 2005;162:867-75 «PMID: 15863787»PubMed
  195. Zlotnick C, Mattia JI, Zimmerman M. Clinical correlates of self-mutilation in a sample of general psychiatric patients. J Nerv Ment Dis 1999;187:296-301 «PMID: 10348084»PubMed